Results 131 to 140 of about 11,164 (212)

The Structure of Tanshinone-II [PDF]

Bulletin of the Chemical Society of Japan, 1961
Yasuaki Okumura, Hiroshi Kakisawa, Mitsuko Kato, Yoshimasa Hirata   +3 more
openaire   +1 more source

Tanshinone IIA prevents septicemia acute kidney injury via regulating the DUSP10/JNK/P38/NLRP3 pathway. [PDF]

Am J Transl Res
Wen D, Deng Q, Zeng Y, Li L, Yang X, Chen Q, Yan Y, Lv J.   +7 more
europepmc   +1 more source

Development of a Series of Tanshinone Derivatives Through Scaffold Hopping for Treating Non-Small-Cell Lung Cancer (NSCLC). [PDF]

Molecules
Zhou LX, Shu ZY, Li H, Zhong H, Xu DN, Tang L, Hu CJ, Luo C, Xiong H.   +8 more
europepmc   +1 more source

Dihydrotanshinone as a Natural Product-Based CYP17A1 Lyase Inhibitor for Hyperandrogenic Disorders. [PDF]

Biomolecules
Li K, Yakubu J, Jørgensen FS, Pandey AV.   +3 more
europepmc   +1 more source

Transformer-based graphs for drug-drug interaction with chemical knowledge embedding. [PDF]

Brief Bioinform
Zhang J, Zhang X, Dai Y, Shao X, Fan X.
europepmc   +1 more source

Efficacy and safety of Traditional Chinese Medicine injections for no-reflow or slow flow in patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Cai T, Li W, Xu W, Lin C, Liang L, Wang D, Zheng J.   +6 more
europepmc   +1 more source

Tanshinone IIA alleviates LPS-induced acute kidney injury by inhibiting RIP3/Nrf2-mediated oxidative stress. [PDF]

Ren Fail
Zhang S, Dong X, Chen G, Wang C.
europepmc   +1 more source

The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial [PDF]

, 2016
Hong-Li Ma, Jian-Ping Liu, Jin Sun, Kang Zhang, Qian-Yun Chai, Xiao-Ke Wu, Ying Zhang, Yun-Jiao Zhang   +7 more
core   +1 more source

Pharmacological Effects and Mechanisms of Tanshinone IIA in Bone Injury Repair. [PDF]

Pharmaceuticals (Basel)
Hu W, Si Y, Wen X, Lin D, Yu Z, Xie X, Xu J.   +6 more
europepmc   +1 more source

Research progress on the molecular mechanisms of tanshinone IIA in the treatment of cardiovascular and cerebrovascular diseases (Review). [PDF]

Int J Mol Med
Pei W, Lu P, Ding C, Li Y, Li Y.
europepmc   +1 more source